查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1954260

长读长定序市场分析及至2035年预测：依类型、产品、服务、技术、应用、最终用户、组件、设备、流程、部署类型及模式划分

Long Read Sequencing Market Analysis and Forecast to 2035: Type, Product, Services, Technology, Application, End User, Component, Device, Process, Installation Type
出版日期: | 出版商: Global Insight Services | 英文 334 Pages | 商品交期: 3-5个工作天内

价格
简介目录

预计长读长定序市场将从2024年的24亿美元成长到2034年的91亿美元，复合年增长率约为12.2%。长读长定序市场涵盖了先进的基因测序技术，能够读取长DNA或RNA片段，从而提供对复杂遗传结构的全面洞察。精准医疗、个人化医疗和基因组研究的需求是推动该市场成长的主要因素。其主要应用包括罕见疾病诊断、癌症基因组学和农业生物技术。创新的重点在于提高定序的准确性、速度和成本效益，以满足​​研究人员和医疗保健提供者对详细遗传资讯的需求。

受基因组研究和个人化医疗发展趋势的推动，长读长定序市场正经历显着成长。其中，耗材细分市场成长最快，这主要得益于定序过程中对试剂和试剂盒的持续需求。其次是设备细分市场，定序平台的不断创新提高了数据准确性和通量。在各个子细分市场中，单分子即时定序凭藉其更长的读长和更高的准确性主导。奈米孔定序因其便携性和即时数据生成能力而备受关注，成为第二大成长细分市场。服务区隔也呈现强劲成长，这主要得益于科研机构和製药公司对定序服务的外包需求不断增加。随着对全面基因组资讯的需求日益增长，定序技术和生物资讯解决方案的持续发展将带来新的机会并推动未来的进步，预计市场将进一步扩张。

市场区隔
类型 单分子即时定序、奈米孔定序、合成长读长定序
产品 设备、耗材和软体
服务 定序服务、生物资讯服务
科技 SMRT定序、奈米孔定序
目的 全基因组定序、表观遗传学、转录组学、总体基因体学、结构突变检测
最终用户 学术研究机构、製药和生物技术公司、医院和诊所
成分 硬体和软体
流程 样品製备、定序与数据分析
实施表格 本机部署、云端部署
模式 研究模式、临床模式

长读长定序市场竞争激烈，各厂商都试图透过极具竞争力的价格策略和创新产品推出来扩大市场份额。快速的技术创新正在加速尖端定序平台的普及应用。这些创新旨在提高定序的准确性和速度，以满足日益增长的全面基因组分析需求。同时，价格竞争仍然激烈，各公司都在努力提供兼顾成本效益和品质的解决方案。旨在拓展产品系列和增强全球影响力的策略联盟和伙伴关係进一步加剧了这种竞争格局。在竞争基准方面，许多主要厂商都在利用自身的技术能力来维持竞争优势。监管环境至关重要，严格的指导方针影响产品开发和打入市场策略。北美和欧洲凭藉健全的法规结构和高普及率处于领先地位。亚太地区正崛起为一个充满潜力的市场，其特点是医疗基础设施和研究倡议投资不断增加。预计在定序技术进步和对个人化医疗日益重视的推动下，亚太市场将实现显着成长。儘管监管合规和高营运成本等挑战依然存在，但创新和市场扩张的潜力依然巨大。

主要趋势和驱动因素：

长读长定序市场正经历强劲成长，这主要得益于多种动态趋势和驱动因素。其中一个关键趋势是对全面基因组分析的需求日益增长，而长读长定序技术恰好能够满足这项需求。这些技术能够提供无与伦比的准确性和洞察力，尤其是在复杂的基因组区域，推动了其在各种研究和临床环境中的应用。此外，生物资讯学和数据分析的进步也提升了长读长定序的效用。这些进步使得资料处理和解读更加高效，使研究人员更容易获得这些技术，并从中受益。同时，定序成本的下降也使小规模机构和新兴市场能够投资于这些前沿解决方案，从而提高了定序技术的普及度。个人化医疗的日益普及也推动了市场的发展，因为详细的基因资讯对于个人化治疗至关重要。长读长定定序能够提供全面的基因组讯息，使其成为这一新兴领域的重要工具。此外，学术机构和产业界的合作正在促进创新并拓展应用领域，进一步加速市场成长。遗传疾病的日益增加以及对精准诊断工具的需求，是推动长读长定序市场向前发展的其他驱动因素。

目录

第一章执行摘要

第二章 市集亮点

第三章 市场动态

  • 宏观经济分析
  • 市场趋势
  • 市场驱动因素
  • 市场机会
  • 市场限制
  • 复合年均成长率：成长分析
  • 影响分析
  • 新兴市场
  • 技术蓝图
  • 战略框架

第四章 细分市场分析

  • 市场规模及预测：依类型
    • 单分子即时定序
    • 奈米孔定序
    • 合成长读定序
  • 市场规模及预测：依产品划分
    • 装置
    • 消耗品
    • 软体
  • 市场规模及预测：依服务划分
    • 定序服务
    • 生物资讯服务
  • 市场规模及预测：依技术划分
    • SMRT定序
    • 奈米孔定序
  • 市场规模及预测：依应用领域划分
    • 全基因测序
    • 表观遗传学
    • 转录组学
    • 总体基因体学
    • 结构突变检测
  • 市场规模及预测：依最终用户划分
    • 学术研究机构
    • 製药和生物技术公司
    • 医院和诊所
  • 市场规模及预测：依组件划分
    • 硬体
    • 软体
  • 市场规模及预测：依製程划分
    • 样品製备
    • 定序
    • 数据分析
  • 市场规模及预测：依实施类型划分
    • 本地部署
    • 基于云端的
  • 市场规模及预测：按模式
    • 研究模式
    • 临床模式

第五章 区域分析

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 其他拉丁美洲地区
  • 亚太地区
    • 中国
    • 印度
    • 韩国
    • 日本
    • 澳洲
    • 台湾
    • 亚太其他地区
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 西班牙
    • 义大利
    • 其他欧洲地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非
    • 撒哈拉以南非洲
    • 其他中东和非洲地区

第六章 市场策略

  • 需求与供给差距分析
  • 贸易和物流限制
  • 价格、成本和利润率趋势
  • 市场渗透率
  • 消费者分析
  • 法规概述

第七章 竞争讯息

  • 市场定位
  • 市场占有率
  • 竞争基准
  • 主要企业的策略

第八章 公司简介

  • Pacific Biosciences
  • Oxford Nanopore Technologies
  • Genapsys
  • Stratos Genomics
  • Element Biosciences
  • Quantum-Si
  • Dovetail Genomics
  • Genome Transcriptome Facility of Bordeaux
  • Seq LL
  • Bionano Genomics
  • Tecan Genomics
  • Arima Genomics
  • 10x Genomics
  • Gencove
  • Twist Bioscience
  • Bio Skryb Genomics
  • Nu GEN Technologies
  • Longas Technologies
  • Loop Genomics
  • Base Genomics

第九章：关于我们

简介目录
Product Code: GIS10506

Long Read Sequencing Market is anticipated to expand from $2.4 billion in 2024 to $9.1 billion by 2034, growing at a CAGR of approximately 12.2%. The Long Read Sequencing Market encompasses advanced genomic sequencing technologies that enable the reading of long DNA or RNA fragments, providing comprehensive insights into complex genetic structures. This market is driven by the demand for precision medicine, personalized healthcare, and research in genomics. Key applications include rare disease diagnosis, cancer genomics, and agricultural biotechnology. Innovations focus on improving accuracy, speed, and cost-effectiveness, addressing the needs of researchers and healthcare providers for detailed genetic information.

The Long Read Sequencing Market is experiencing significant growth, fueled by advancements in genomic research and personalized medicine. Within this market, the consumables segment is the top performer, driven by the recurring need for reagents and kits in sequencing processes. Instruments follow closely, with continuous innovations in sequencing platforms enhancing data accuracy and throughput. Among the sub-segments, single-molecule real-time sequencing is leading due to its capability to provide longer read lengths and higher accuracy. Nanopore sequencing is the second highest performing sub-segment, gaining traction for its portability and real-time data generation. The services segment is also witnessing robust growth, as outsourcing of sequencing services becomes more prevalent among research institutions and pharmaceutical companies. As the demand for comprehensive genomic insights rises, the market is poised for further expansion, with ongoing developments in sequencing technologies and bioinformatics solutions promising to unlock new opportunities and drive future advancements.

Market Segmentation
TypeSingle-Molecule Real-Time Sequencing, Nanopore Sequencing, Synthetic Long Read Sequencing
ProductInstruments, Consumables, Software
ServicesSequencing Services, Bioinformatics Services
TechnologySMRT Sequencing, Nanopore Sequencing
ApplicationWhole Genome Sequencing, Epigenetics, Transcriptomics, Metagenomics, Structural Variation Detection
End UserAcademic and Research Institutions, Pharmaceutical and Biotechnology Companies, Hospitals and Clinics
ComponentHardware, Software
ProcessLibrary Preparation, Sequencing, Data Analysis
DeploymentOn-Premise, Cloud-Based
ModeResearch Mode, Clinical Mode

The Long Read Sequencing Market is characterized by a diverse array of players, each vying for increased market share through competitive pricing strategies and innovative product launches. The market is witnessing a surge in technological advancements, propelling the introduction of cutting-edge sequencing platforms. These innovations are designed to enhance accuracy and speed, catering to the growing demand for comprehensive genomic analysis. Meanwhile, pricing dynamics remain competitive, with companies striving to offer cost-effective solutions without compromising on quality. This competitive landscape is further intensified by strategic collaborations and partnerships aimed at expanding product portfolios and enhancing global reach. In terms of competition benchmarking, several key players are leveraging their technological prowess to maintain a competitive edge. The regulatory landscape is pivotal, with stringent guidelines shaping product development and market entry strategies. North America and Europe are at the forefront, driven by robust regulatory frameworks and high adoption rates. Asia-Pacific is emerging as a lucrative market, characterized by increasing investments in healthcare infrastructure and research initiatives. The market is poised for substantial growth, driven by advancements in sequencing technologies and the growing emphasis on personalized medicine. Challenges such as regulatory compliance and high operational costs persist, yet the potential for innovation and market expansion remains significant.

Geographical Overview:

The Long Read Sequencing Market is witnessing robust expansion across various regions, each presenting unique growth opportunities. North America leads this market, buoyed by extensive research initiatives and substantial funding. The presence of major biotechnology firms further accelerates market development. Europe follows, with a strong focus on genomics and personalized medicine, attracting significant investments and fostering innovation. In Asia Pacific, the market is growing rapidly, driven by technological advancements and increased healthcare expenditure. Countries like China and India are emerging as key players due to their expanding research capabilities and supportive government policies. Latin America is gaining traction, with rising investments in genomic research and a growing interest in precision medicine. The Middle East & Africa are also showing promise, with increasing awareness and adoption of advanced sequencing technologies. These regions are recognizing the potential of long read sequencing in advancing healthcare and research, thereby presenting lucrative opportunities for market players.

The global imposition of tariffs on biotechnology and sequencing equipment is influencing the Long Read Sequencing Market, particularly in East Asia. Japan and South Korea are navigating increased costs by fostering innovation in sequencing technologies and enhancing domestic capabilities. China's strategic pivot towards self-reliance is evident in its substantial investment in homegrown sequencing technology, mitigating impacts from Western trade barriers. Taiwan, while a pivotal player in semiconductor manufacturing, faces geopolitical vulnerabilities, potentially disrupting its supply chain continuity. The parent genomics market is witnessing robust growth, driven by advancements in personalized medicine and bioinformatics. By 2035, the market is poised for expansion, contingent on geopolitical stability and supply chain resilience. Meanwhile, Middle Eastern conflicts pose risks to global energy prices, indirectly affecting operational costs across the biotechnology sector.

Key Trends and Drivers:

The Long Read Sequencing Market is experiencing robust growth, propelled by several dynamic trends and drivers. One significant trend is the increasing demand for comprehensive genomic analysis, which long read sequencing technologies can uniquely provide. These technologies offer unparalleled accuracy and insight, particularly in complex genomic regions, driving their adoption in various research and clinical settings. Additionally, advancements in bioinformatics and data analytics are enhancing the utility of long read sequencing. They enable more efficient data processing and interpretation, making these technologies more accessible and valuable to researchers. Furthermore, decreasing costs associated with sequencing are democratizing access, allowing smaller institutions and emerging markets to invest in these cutting-edge solutions. The market is also driven by the growing emphasis on personalized medicine, where detailed genetic information is crucial for tailoring treatments. Long read sequencing's ability to deliver comprehensive genomic insights positions it as a critical tool in this evolving field. Moreover, collaborations between academic institutions and industry players are fostering innovation and expanding application areas, further fueling market growth. The increasing prevalence of genetic disorders and the need for precise diagnostic tools are additional drivers propelling the long read sequencing market forward.

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

  • 1.1 Market Size and Forecast
  • 1.2 Market Overview
  • 1.3 Market Snapshot
  • 1.4 Regional Snapshot
  • 1.5 Strategic Recommendations
  • 1.6 Analyst Notes

2 Market Highlights

  • 2.1 Key Market Highlights by Type
  • 2.2 Key Market Highlights by Product
  • 2.3 Key Market Highlights by Services
  • 2.4 Key Market Highlights by Technology
  • 2.5 Key Market Highlights by Application
  • 2.6 Key Market Highlights by End User
  • 2.7 Key Market Highlights by Component
  • 2.8 Key Market Highlights by Process
  • 2.9 Key Market Highlights by Deployment
  • 2.10 Key Market Highlights by Mode

3 Market Dynamics

  • 3.1 Macroeconomic Analysis
  • 3.2 Market Trends
  • 3.3 Market Drivers
  • 3.4 Market Opportunities
  • 3.5 Market Restraints
  • 3.6 CAGR Growth Analysis
  • 3.7 Impact Analysis
  • 3.8 Emerging Markets
  • 3.9 Technology Roadmap
  • 3.10 Strategic Frameworks
    • 3.10.1 PORTER's 5 Forces Model
    • 3.10.2 ANSOFF Matrix
    • 3.10.3 4P's Model
    • 3.10.4 PESTEL Analysis

4 Segment Analysis

  • 4.1 Market Size & Forecast by Type (2020-2035)
    • 4.1.1 Single-Molecule Real-Time Sequencing
    • 4.1.2 Nanopore Sequencing
    • 4.1.3 Synthetic Long Read Sequencing
    • 4.1.4 Others
  • 4.2 Market Size & Forecast by Product (2020-2035)
    • 4.2.1 Instruments
    • 4.2.2 Consumables
    • 4.2.3 Software
    • 4.2.4 Others
  • 4.3 Market Size & Forecast by Services (2020-2035)
    • 4.3.1 Sequencing Services
    • 4.3.2 Bioinformatics Services
    • 4.3.3 Others
  • 4.4 Market Size & Forecast by Technology (2020-2035)
    • 4.4.1 SMRT Sequencing
    • 4.4.2 Nanopore Sequencing
    • 4.4.3 Others
  • 4.5 Market Size & Forecast by Application (2020-2035)
    • 4.5.1 Whole Genome Sequencing
    • 4.5.2 Epigenetics
    • 4.5.3 Transcriptomics
    • 4.5.4 Metagenomics
    • 4.5.5 Structural Variation Detection
    • 4.5.6 Others
  • 4.6 Market Size & Forecast by End User (2020-2035)
    • 4.6.1 Academic and Research Institutions
    • 4.6.2 Pharmaceutical and Biotechnology Companies
    • 4.6.3 Hospitals and Clinics
    • 4.6.4 Others
  • 4.7 Market Size & Forecast by Component (2020-2035)
    • 4.7.1 Hardware
    • 4.7.2 Software
    • 4.7.3 Others
  • 4.8 Market Size & Forecast by Process (2020-2035)
    • 4.8.1 Library Preparation
    • 4.8.2 Sequencing
    • 4.8.3 Data Analysis
    • 4.8.4 Others
  • 4.9 Market Size & Forecast by Deployment (2020-2035)
    • 4.9.1 On-Premise
    • 4.9.2 Cloud-Based
    • 4.9.3 Others
  • 4.10 Market Size & Forecast by Mode (2020-2035)
    • 4.10.1 Research Mode
    • 4.10.2 Clinical Mode
    • 4.10.3 Others

5 Regional Analysis

  • 5.1 Global Market Overview
  • 5.2 North America Market Size (2020-2035)
    • 5.2.1 United States
      • 5.2.1.1 Type
      • 5.2.1.2 Product
      • 5.2.1.3 Services
      • 5.2.1.4 Technology
      • 5.2.1.5 Application
      • 5.2.1.6 End User
      • 5.2.1.7 Component
      • 5.2.1.8 Process
      • 5.2.1.9 Deployment
      • 5.2.1.10 Mode
    • 5.2.2 Canada
      • 5.2.2.1 Type
      • 5.2.2.2 Product
      • 5.2.2.3 Services
      • 5.2.2.4 Technology
      • 5.2.2.5 Application
      • 5.2.2.6 End User
      • 5.2.2.7 Component
      • 5.2.2.8 Process
      • 5.2.2.9 Deployment
      • 5.2.2.10 Mode
    • 5.2.3 Mexico
      • 5.2.3.1 Type
      • 5.2.3.2 Product
      • 5.2.3.3 Services
      • 5.2.3.4 Technology
      • 5.2.3.5 Application
      • 5.2.3.6 End User
      • 5.2.3.7 Component
      • 5.2.3.8 Process
      • 5.2.3.9 Deployment
      • 5.2.3.10 Mode
  • 5.3 Latin America Market Size (2020-2035)
    • 5.3.1 Brazil
      • 5.3.1.1 Type
      • 5.3.1.2 Product
      • 5.3.1.3 Services
      • 5.3.1.4 Technology
      • 5.3.1.5 Application
      • 5.3.1.6 End User
      • 5.3.1.7 Component
      • 5.3.1.8 Process
      • 5.3.1.9 Deployment
      • 5.3.1.10 Mode
    • 5.3.2 Argentina
      • 5.3.2.1 Type
      • 5.3.2.2 Product
      • 5.3.2.3 Services
      • 5.3.2.4 Technology
      • 5.3.2.5 Application
      • 5.3.2.6 End User
      • 5.3.2.7 Component
      • 5.3.2.8 Process
      • 5.3.2.9 Deployment
      • 5.3.2.10 Mode
    • 5.3.3 Rest of Latin America
      • 5.3.3.1 Type
      • 5.3.3.2 Product
      • 5.3.3.3 Services
      • 5.3.3.4 Technology
      • 5.3.3.5 Application
      • 5.3.3.6 End User
      • 5.3.3.7 Component
      • 5.3.3.8 Process
      • 5.3.3.9 Deployment
      • 5.3.3.10 Mode
  • 5.4 Asia-Pacific Market Size (2020-2035)
    • 5.4.1 China
      • 5.4.1.1 Type
      • 5.4.1.2 Product
      • 5.4.1.3 Services
      • 5.4.1.4 Technology
      • 5.4.1.5 Application
      • 5.4.1.6 End User
      • 5.4.1.7 Component
      • 5.4.1.8 Process
      • 5.4.1.9 Deployment
      • 5.4.1.10 Mode
    • 5.4.2 India
      • 5.4.2.1 Type
      • 5.4.2.2 Product
      • 5.4.2.3 Services
      • 5.4.2.4 Technology
      • 5.4.2.5 Application
      • 5.4.2.6 End User
      • 5.4.2.7 Component
      • 5.4.2.8 Process
      • 5.4.2.9 Deployment
      • 5.4.2.10 Mode
    • 5.4.3 South Korea
      • 5.4.3.1 Type
      • 5.4.3.2 Product
      • 5.4.3.3 Services
      • 5.4.3.4 Technology
      • 5.4.3.5 Application
      • 5.4.3.6 End User
      • 5.4.3.7 Component
      • 5.4.3.8 Process
      • 5.4.3.9 Deployment
      • 5.4.3.10 Mode
    • 5.4.4 Japan
      • 5.4.4.1 Type
      • 5.4.4.2 Product
      • 5.4.4.3 Services
      • 5.4.4.4 Technology
      • 5.4.4.5 Application
      • 5.4.4.6 End User
      • 5.4.4.7 Component
      • 5.4.4.8 Process
      • 5.4.4.9 Deployment
      • 5.4.4.10 Mode
    • 5.4.5 Australia
      • 5.4.5.1 Type
      • 5.4.5.2 Product
      • 5.4.5.3 Services
      • 5.4.5.4 Technology
      • 5.4.5.5 Application
      • 5.4.5.6 End User
      • 5.4.5.7 Component
      • 5.4.5.8 Process
      • 5.4.5.9 Deployment
      • 5.4.5.10 Mode
    • 5.4.6 Taiwan
      • 5.4.6.1 Type
      • 5.4.6.2 Product
      • 5.4.6.3 Services
      • 5.4.6.4 Technology
      • 5.4.6.5 Application
      • 5.4.6.6 End User
      • 5.4.6.7 Component
      • 5.4.6.8 Process
      • 5.4.6.9 Deployment
      • 5.4.6.10 Mode
    • 5.4.7 Rest of APAC
      • 5.4.7.1 Type
      • 5.4.7.2 Product
      • 5.4.7.3 Services
      • 5.4.7.4 Technology
      • 5.4.7.5 Application
      • 5.4.7.6 End User
      • 5.4.7.7 Component
      • 5.4.7.8 Process
      • 5.4.7.9 Deployment
      • 5.4.7.10 Mode
  • 5.5 Europe Market Size (2020-2035)
    • 5.5.1 Germany
      • 5.5.1.1 Type
      • 5.5.1.2 Product
      • 5.5.1.3 Services
      • 5.5.1.4 Technology
      • 5.5.1.5 Application
      • 5.5.1.6 End User
      • 5.5.1.7 Component
      • 5.5.1.8 Process
      • 5.5.1.9 Deployment
      • 5.5.1.10 Mode
    • 5.5.2 France
      • 5.5.2.1 Type
      • 5.5.2.2 Product
      • 5.5.2.3 Services
      • 5.5.2.4 Technology
      • 5.5.2.5 Application
      • 5.5.2.6 End User
      • 5.5.2.7 Component
      • 5.5.2.8 Process
      • 5.5.2.9 Deployment
      • 5.5.2.10 Mode
    • 5.5.3 United Kingdom
      • 5.5.3.1 Type
      • 5.5.3.2 Product
      • 5.5.3.3 Services
      • 5.5.3.4 Technology
      • 5.5.3.5 Application
      • 5.5.3.6 End User
      • 5.5.3.7 Component
      • 5.5.3.8 Process
      • 5.5.3.9 Deployment
      • 5.5.3.10 Mode
    • 5.5.4 Spain
      • 5.5.4.1 Type
      • 5.5.4.2 Product
      • 5.5.4.3 Services
      • 5.5.4.4 Technology
      • 5.5.4.5 Application
      • 5.5.4.6 End User
      • 5.5.4.7 Component
      • 5.5.4.8 Process
      • 5.5.4.9 Deployment
      • 5.5.4.10 Mode
    • 5.5.5 Italy
      • 5.5.5.1 Type
      • 5.5.5.2 Product
      • 5.5.5.3 Services
      • 5.5.5.4 Technology
      • 5.5.5.5 Application
      • 5.5.5.6 End User
      • 5.5.5.7 Component
      • 5.5.5.8 Process
      • 5.5.5.9 Deployment
      • 5.5.5.10 Mode
    • 5.5.6 Rest of Europe
      • 5.5.6.1 Type
      • 5.5.6.2 Product
      • 5.5.6.3 Services
      • 5.5.6.4 Technology
      • 5.5.6.5 Application
      • 5.5.6.6 End User
      • 5.5.6.7 Component
      • 5.5.6.8 Process
      • 5.5.6.9 Deployment
      • 5.5.6.10 Mode
  • 5.6 Middle East & Africa Market Size (2020-2035)
    • 5.6.1 Saudi Arabia
      • 5.6.1.1 Type
      • 5.6.1.2 Product
      • 5.6.1.3 Services
      • 5.6.1.4 Technology
      • 5.6.1.5 Application
      • 5.6.1.6 End User
      • 5.6.1.7 Component
      • 5.6.1.8 Process
      • 5.6.1.9 Deployment
      • 5.6.1.10 Mode
    • 5.6.2 United Arab Emirates
      • 5.6.2.1 Type
      • 5.6.2.2 Product
      • 5.6.2.3 Services
      • 5.6.2.4 Technology
      • 5.6.2.5 Application
      • 5.6.2.6 End User
      • 5.6.2.7 Component
      • 5.6.2.8 Process
      • 5.6.2.9 Deployment
      • 5.6.2.10 Mode
    • 5.6.3 South Africa
      • 5.6.3.1 Type
      • 5.6.3.2 Product
      • 5.6.3.3 Services
      • 5.6.3.4 Technology
      • 5.6.3.5 Application
      • 5.6.3.6 End User
      • 5.6.3.7 Component
      • 5.6.3.8 Process
      • 5.6.3.9 Deployment
      • 5.6.3.10 Mode
    • 5.6.4 Sub-Saharan Africa
      • 5.6.4.1 Type
      • 5.6.4.2 Product
      • 5.6.4.3 Services
      • 5.6.4.4 Technology
      • 5.6.4.5 Application
      • 5.6.4.6 End User
      • 5.6.4.7 Component
      • 5.6.4.8 Process
      • 5.6.4.9 Deployment
      • 5.6.4.10 Mode
    • 5.6.5 Rest of MEA
      • 5.6.5.1 Type
      • 5.6.5.2 Product
      • 5.6.5.3 Services
      • 5.6.5.4 Technology
      • 5.6.5.5 Application
      • 5.6.5.6 End User
      • 5.6.5.7 Component
      • 5.6.5.8 Process
      • 5.6.5.9 Deployment
      • 5.6.5.10 Mode

6 Market Strategy

  • 6.1 Demand-Supply Gap Analysis
  • 6.2 Trade & Logistics Constraints
  • 6.3 Price-Cost-Margin Trends
  • 6.4 Market Penetration
  • 6.5 Consumer Analysis
  • 6.6 Regulatory Snapshot

7 Competitive Intelligence

  • 7.1 Market Positioning
  • 7.2 Market Share
  • 7.3 Competition Benchmarking
  • 7.4 Top Company Strategies

8 Company Profiles

  • 8.1 Pacific Biosciences
    • 8.1.1 Overview
    • 8.1.2 Product Summary
    • 8.1.3 Financial Performance
    • 8.1.4 SWOT Analysis
  • 8.2 Oxford Nanopore Technologies
    • 8.2.1 Overview
    • 8.2.2 Product Summary
    • 8.2.3 Financial Performance
    • 8.2.4 SWOT Analysis
  • 8.3 Genapsys
    • 8.3.1 Overview
    • 8.3.2 Product Summary
    • 8.3.3 Financial Performance
    • 8.3.4 SWOT Analysis
  • 8.4 Stratos Genomics
    • 8.4.1 Overview
    • 8.4.2 Product Summary
    • 8.4.3 Financial Performance
    • 8.4.4 SWOT Analysis
  • 8.5 Element Biosciences
    • 8.5.1 Overview
    • 8.5.2 Product Summary
    • 8.5.3 Financial Performance
    • 8.5.4 SWOT Analysis
  • 8.6 Quantum- Si
    • 8.6.1 Overview
    • 8.6.2 Product Summary
    • 8.6.3 Financial Performance
    • 8.6.4 SWOT Analysis
  • 8.7 Dovetail Genomics
    • 8.7.1 Overview
    • 8.7.2 Product Summary
    • 8.7.3 Financial Performance
    • 8.7.4 SWOT Analysis
  • 8.8 Genome Transcriptome Facility of Bordeaux
    • 8.8.1 Overview
    • 8.8.2 Product Summary
    • 8.8.3 Financial Performance
    • 8.8.4 SWOT Analysis
  • 8.9 Seq LL
    • 8.9.1 Overview
    • 8.9.2 Product Summary
    • 8.9.3 Financial Performance
    • 8.9.4 SWOT Analysis
  • 8.10 Bionano Genomics
    • 8.10.1 Overview
    • 8.10.2 Product Summary
    • 8.10.3 Financial Performance
    • 8.10.4 SWOT Analysis
  • 8.11 Tecan Genomics
    • 8.11.1 Overview
    • 8.11.2 Product Summary
    • 8.11.3 Financial Performance
    • 8.11.4 SWOT Analysis
  • 8.12 Arima Genomics
    • 8.12.1 Overview
    • 8.12.2 Product Summary
    • 8.12.3 Financial Performance
    • 8.12.4 SWOT Analysis
  • 8.13 10x Genomics
    • 8.13.1 Overview
    • 8.13.2 Product Summary
    • 8.13.3 Financial Performance
    • 8.13.4 SWOT Analysis
  • 8.14 Gencove
    • 8.14.1 Overview
    • 8.14.2 Product Summary
    • 8.14.3 Financial Performance
    • 8.14.4 SWOT Analysis
  • 8.15 Twist Bioscience
    • 8.15.1 Overview
    • 8.15.2 Product Summary
    • 8.15.3 Financial Performance
    • 8.15.4 SWOT Analysis
  • 8.16 Bio Skryb Genomics
    • 8.16.1 Overview
    • 8.16.2 Product Summary
    • 8.16.3 Financial Performance
    • 8.16.4 SWOT Analysis
  • 8.17 Nu GEN Technologies
    • 8.17.1 Overview
    • 8.17.2 Product Summary
    • 8.17.3 Financial Performance
    • 8.17.4 SWOT Analysis
  • 8.18 Longas Technologies
    • 8.18.1 Overview
    • 8.18.2 Product Summary
    • 8.18.3 Financial Performance
    • 8.18.4 SWOT Analysis
  • 8.19 Loop Genomics
    • 8.19.1 Overview
    • 8.19.2 Product Summary
    • 8.19.3 Financial Performance
    • 8.19.4 SWOT Analysis
  • 8.20 Base Genomics
    • 8.20.1 Overview
    • 8.20.2 Product Summary
    • 8.20.3 Financial Performance
    • 8.20.4 SWOT Analysis

9 About Us

  • 9.1 About Us
  • 9.2 Research Methodology
  • 9.3 Research Workflow
  • 9.4 Consulting Services
  • 9.5 Our Clients
  • 9.6 Client Testimonials
  • 9.7 Contact Us